stella
beta
Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer — Stella
Recruiting
Back to EGFR trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov